THE European Commission has
issued its first ever “paediatric use
marketing authorisation,” with
Buccolam (midazolam for buccal
administration) specifically licensed
to treat convulsions and epileptic
seizures in children aged three
months to 18 years.
The move has been welcomed by
the UK Medicines and Healthcare
products Regulatory Agency, which
has long advocated for specific
children’s-only medicines - rather
than simply reduced doses of adult
medications.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Sep 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Sep 11
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.